nodes	percent_of_prediction	percent_of_DWPC	metapath
Lomitapide—ABCB1—Mitomycin—urinary bladder cancer	0.24	0.379	CbGbCtD
Lomitapide—CYP3A4—Thiotepa—urinary bladder cancer	0.109	0.172	CbGbCtD
Lomitapide—ABCB1—Gemcitabine—urinary bladder cancer	0.0691	0.109	CbGbCtD
Lomitapide—ABCB1—Cisplatin—urinary bladder cancer	0.0502	0.0792	CbGbCtD
Lomitapide—ABCB1—Etoposide—urinary bladder cancer	0.0493	0.0779	CbGbCtD
Lomitapide—ABCB1—Doxorubicin—urinary bladder cancer	0.0336	0.0531	CbGbCtD
Lomitapide—ABCB1—Methotrexate—urinary bladder cancer	0.0326	0.0514	CbGbCtD
Lomitapide—CYP3A4—Etoposide—urinary bladder cancer	0.0295	0.0466	CbGbCtD
Lomitapide—CYP3A4—Doxorubicin—urinary bladder cancer	0.0202	0.0318	CbGbCtD
Lomitapide—MTTP—prostate gland—urinary bladder cancer	0.0178	0.313	CbGeAlD
Lomitapide—MTTP—renal system—urinary bladder cancer	0.0121	0.213	CbGeAlD
Lomitapide—MTTP—female reproductive system—urinary bladder cancer	0.00969	0.171	CbGeAlD
Lomitapide—CYP3A4—urine—urinary bladder cancer	0.00617	0.109	CbGeAlD
Lomitapide—Antrafenine—PTGS2—urinary bladder cancer	0.0026	1	CrCbGaD
Lomitapide—ABCB1—Codeine and Morphine Metabolism—UGT2B7—urinary bladder cancer	0.00243	0.0969	CbGpPWpGaD
Lomitapide—ABCB1—prostate gland—urinary bladder cancer	0.00157	0.0276	CbGeAlD
Lomitapide—MTTP—Circadian rythm related genes—KMT2A—urinary bladder cancer	0.00157	0.0625	CbGpPWpGaD
Lomitapide—CYP3A4—renal system—urinary bladder cancer	0.00151	0.0266	CbGeAlD
Lomitapide—CYP3A4—Codeine and Morphine Metabolism—UGT2B7—urinary bladder cancer	0.0015	0.0597	CbGpPWpGaD
Lomitapide—ABCB1—seminal vesicle—urinary bladder cancer	0.00133	0.0234	CbGeAlD
Lomitapide—CYP3A4—female reproductive system—urinary bladder cancer	0.00121	0.0213	CbGeAlD
Lomitapide—ABCB1—epithelium—urinary bladder cancer	0.00115	0.0203	CbGeAlD
Lomitapide—ABCB1—renal system—urinary bladder cancer	0.00107	0.0188	CbGeAlD
Lomitapide—ABCB1—urethra—urinary bladder cancer	0.00105	0.0185	CbGeAlD
Lomitapide—ABCB1—female reproductive system—urinary bladder cancer	0.000855	0.0151	CbGeAlD
Lomitapide—CYP3A4—Estrogen metabolism—UGT2B7—urinary bladder cancer	0.000782	0.0312	CbGpPWpGaD
Lomitapide—ABCB1—vagina—urinary bladder cancer	0.000774	0.0136	CbGeAlD
Lomitapide—CYP3A4—Tamoxifen metabolism—UGT2B7—urinary bladder cancer	0.000692	0.0276	CbGpPWpGaD
Lomitapide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP4B1—urinary bladder cancer	0.000687	0.0274	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.00066	0.0263	CbGpPWpGaD
Lomitapide—CYP3A4—Oxidation by Cytochrome P450—POR—urinary bladder cancer	0.000561	0.0224	CbGpPWpGaD
Lomitapide—MTTP—Circadian rythm related genes—TYMS—urinary bladder cancer	0.000504	0.0201	CbGpPWpGaD
Lomitapide—ABCB1—lymph node—urinary bladder cancer	0.0005	0.00882	CbGeAlD
Lomitapide—MTTP—Circadian rythm related genes—NCOR1—urinary bladder cancer	0.000498	0.0199	CbGpPWpGaD
Lomitapide—CYP3A4—Aflatoxin B1 metabolism—GSTM1—urinary bladder cancer	0.000493	0.0197	CbGpPWpGaD
Lomitapide—Ill-defined disorder—Etoposide—urinary bladder cancer	0.000463	0.00164	CcSEcCtD
Lomitapide—Anaemia—Etoposide—urinary bladder cancer	0.000462	0.00164	CcSEcCtD
Lomitapide—Hyperhidrosis—Gemcitabine—urinary bladder cancer	0.000461	0.00163	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—urinary bladder cancer	0.000461	0.00163	CcSEcCtD
Lomitapide—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.00046	0.00163	CcSEcCtD
Lomitapide—Liver function test abnormal—Methotrexate—urinary bladder cancer	0.000459	0.00162	CcSEcCtD
Lomitapide—Discomfort—Cisplatin—urinary bladder cancer	0.000459	0.00162	CcSEcCtD
Lomitapide—Increased appetite—Doxorubicin—urinary bladder cancer	0.000458	0.00162	CcSEcCtD
Lomitapide—Migraine—Epirubicin—urinary bladder cancer	0.000458	0.00162	CcSEcCtD
Lomitapide—Malaise—Etoposide—urinary bladder cancer	0.00045	0.0016	CcSEcCtD
Lomitapide—Dermatitis bullous—Doxorubicin—urinary bladder cancer	0.00045	0.00159	CcSEcCtD
Lomitapide—Vertigo—Etoposide—urinary bladder cancer	0.000449	0.00159	CcSEcCtD
Lomitapide—Body temperature increased—Thiotepa—urinary bladder cancer	0.000449	0.00159	CcSEcCtD
Lomitapide—Abdominal pain—Thiotepa—urinary bladder cancer	0.000449	0.00159	CcSEcCtD
Lomitapide—MTTP—Circadian rythm related genes—FAS—urinary bladder cancer	0.000447	0.0178	CbGpPWpGaD
Lomitapide—Infection—Cisplatin—urinary bladder cancer	0.000442	0.00157	CcSEcCtD
Lomitapide—Nervous system disorder—Cisplatin—urinary bladder cancer	0.000436	0.00155	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.000435	0.00154	CcSEcCtD
Lomitapide—Dehydration—Epirubicin—urinary bladder cancer	0.000432	0.00153	CcSEcCtD
Lomitapide—Skin disorder—Cisplatin—urinary bladder cancer	0.000432	0.00153	CcSEcCtD
Lomitapide—Pain in extremity—Doxorubicin—urinary bladder cancer	0.00043	0.00152	CcSEcCtD
Lomitapide—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.00043	0.00152	CcSEcCtD
Lomitapide—Liver function test abnormal—Epirubicin—urinary bladder cancer	0.000429	0.00152	CcSEcCtD
Lomitapide—Paraesthesia—Gemcitabine—urinary bladder cancer	0.000429	0.00152	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.000428	0.00151	CcSEcCtD
Lomitapide—Dry skin—Epirubicin—urinary bladder cancer	0.000426	0.00151	CcSEcCtD
Lomitapide—Chest pain—Etoposide—urinary bladder cancer	0.000425	0.00151	CcSEcCtD
Lomitapide—Abdominal pain upper—Epirubicin—urinary bladder cancer	0.000425	0.0015	CcSEcCtD
Lomitapide—Somnolence—Gemcitabine—urinary bladder cancer	0.000424	0.0015	CcSEcCtD
Lomitapide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP4B1—urinary bladder cancer	0.000423	0.0169	CbGpPWpGaD
Lomitapide—Migraine—Doxorubicin—urinary bladder cancer	0.000423	0.0015	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.000422	0.0015	CcSEcCtD
Lomitapide—Paraesthesia—Fluorouracil—urinary bladder cancer	0.000421	0.00149	CcSEcCtD
Lomitapide—Discomfort—Etoposide—urinary bladder cancer	0.00042	0.00149	CcSEcCtD
Lomitapide—Aspartate aminotransferase increased—Epirubicin—urinary bladder cancer	0.000419	0.00148	CcSEcCtD
Lomitapide—Somnolence—Fluorouracil—urinary bladder cancer	0.000417	0.00148	CcSEcCtD
Lomitapide—Nasopharyngitis—Epirubicin—urinary bladder cancer	0.000416	0.00147	CcSEcCtD
Lomitapide—Decreased appetite—Gemcitabine—urinary bladder cancer	0.000415	0.00147	CcSEcCtD
Lomitapide—Dyspepsia—Fluorouracil—urinary bladder cancer	0.000413	0.00146	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.000412	0.00146	CcSEcCtD
Lomitapide—Abdominal discomfort—Methotrexate—urinary bladder cancer	0.000412	0.00146	CcSEcCtD
Lomitapide—Fatigue—Gemcitabine—urinary bladder cancer	0.000411	0.00146	CcSEcCtD
Lomitapide—Gastritis—Epirubicin—urinary bladder cancer	0.000411	0.00146	CcSEcCtD
Lomitapide—Alanine aminotransferase increased—Epirubicin—urinary bladder cancer	0.00041	0.00145	CcSEcCtD
Lomitapide—Constipation—Gemcitabine—urinary bladder cancer	0.000408	0.00145	CcSEcCtD
Lomitapide—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000408	0.00145	CcSEcCtD
Lomitapide—Asthenia—Thiotepa—urinary bladder cancer	0.000407	0.00144	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.000405	0.00144	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.000405	0.00144	CcSEcCtD
Lomitapide—Infection—Etoposide—urinary bladder cancer	0.000405	0.00143	CcSEcCtD
Lomitapide—Abdominal distension—Epirubicin—urinary bladder cancer	0.000404	0.00143	CcSEcCtD
Lomitapide—Influenza—Epirubicin—urinary bladder cancer	0.000402	0.00142	CcSEcCtD
Lomitapide—Dehydration—Doxorubicin—urinary bladder cancer	0.0004	0.00142	CcSEcCtD
Lomitapide—Paraesthesia—Cisplatin—urinary bladder cancer	0.000399	0.00142	CcSEcCtD
Lomitapide—Liver function test abnormal—Doxorubicin—urinary bladder cancer	0.000397	0.00141	CcSEcCtD
Lomitapide—Skin disorder—Etoposide—urinary bladder cancer	0.000396	0.0014	CcSEcCtD
Lomitapide—Dry skin—Doxorubicin—urinary bladder cancer	0.000394	0.0014	CcSEcCtD
Lomitapide—Hyperhidrosis—Etoposide—urinary bladder cancer	0.000394	0.0014	CcSEcCtD
Lomitapide—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000393	0.00139	CcSEcCtD
Lomitapide—MTTP—Circadian rythm related genes—CDK4—urinary bladder cancer	0.000393	0.0157	CbGpPWpGaD
Lomitapide—Abdominal pain upper—Doxorubicin—urinary bladder cancer	0.000393	0.00139	CcSEcCtD
Lomitapide—Angina pectoris—Epirubicin—urinary bladder cancer	0.000391	0.00139	CcSEcCtD
Lomitapide—Diarrhoea—Thiotepa—urinary bladder cancer	0.000388	0.00138	CcSEcCtD
Lomitapide—Aspartate aminotransferase increased—Doxorubicin—urinary bladder cancer	0.000387	0.00137	CcSEcCtD
Lomitapide—Decreased appetite—Cisplatin—urinary bladder cancer	0.000387	0.00137	CcSEcCtD
Lomitapide—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000387	0.00137	CcSEcCtD
Lomitapide—Nasopharyngitis—Doxorubicin—urinary bladder cancer	0.000385	0.00136	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000384	0.00136	CcSEcCtD
Lomitapide—Infestation—Methotrexate—urinary bladder cancer	0.000383	0.00136	CcSEcCtD
Lomitapide—Infestation NOS—Methotrexate—urinary bladder cancer	0.000383	0.00136	CcSEcCtD
Lomitapide—Gastritis—Doxorubicin—urinary bladder cancer	0.000381	0.00135	CcSEcCtD
Lomitapide—Alanine aminotransferase increased—Doxorubicin—urinary bladder cancer	0.000379	0.00134	CcSEcCtD
Lomitapide—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000377	0.00134	CcSEcCtD
Lomitapide—MTTP—Metabolism—GSTZ1—urinary bladder cancer	0.000376	0.015	CbGpPWpGaD
Lomitapide—Dizziness—Thiotepa—urinary bladder cancer	0.000375	0.00133	CcSEcCtD
Lomitapide—Abdominal distension—Doxorubicin—urinary bladder cancer	0.000374	0.00133	CcSEcCtD
Lomitapide—Influenza—Doxorubicin—urinary bladder cancer	0.000372	0.00132	CcSEcCtD
Lomitapide—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000371	0.00131	CcSEcCtD
Lomitapide—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000367	0.0013	CcSEcCtD
Lomitapide—Paraesthesia—Etoposide—urinary bladder cancer	0.000366	0.0013	CcSEcCtD
Lomitapide—Haematuria—Methotrexate—urinary bladder cancer	0.000365	0.00129	CcSEcCtD
Lomitapide—Weight decreased—Epirubicin—urinary bladder cancer	0.000363	0.00129	CcSEcCtD
Lomitapide—Somnolence—Etoposide—urinary bladder cancer	0.000362	0.00128	CcSEcCtD
Lomitapide—Angina pectoris—Doxorubicin—urinary bladder cancer	0.000362	0.00128	CcSEcCtD
Lomitapide—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.000362	0.00128	CcSEcCtD
Lomitapide—Vomiting—Thiotepa—urinary bladder cancer	0.000361	0.00128	CcSEcCtD
Lomitapide—Infestation—Epirubicin—urinary bladder cancer	0.000358	0.00127	CcSEcCtD
Lomitapide—Infestation NOS—Epirubicin—urinary bladder cancer	0.000358	0.00127	CcSEcCtD
Lomitapide—MTTP—Circadian rythm related genes—PPARG—urinary bladder cancer	0.000357	0.0143	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—GSTO2—urinary bladder cancer	0.000357	0.0142	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—NAT1—urinary bladder cancer	0.000357	0.0142	CbGpPWpGaD
Lomitapide—Headache—Thiotepa—urinary bladder cancer	0.000355	0.00126	CcSEcCtD
Lomitapide—Decreased appetite—Etoposide—urinary bladder cancer	0.000354	0.00126	CcSEcCtD
Lomitapide—ABCB1—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.000352	0.0141	CbGpPWpGaD
Lomitapide—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000352	0.00125	CcSEcCtD
Lomitapide—Body temperature increased—Cisplatin—urinary bladder cancer	0.000352	0.00125	CcSEcCtD
Lomitapide—Fatigue—Etoposide—urinary bladder cancer	0.000351	0.00125	CcSEcCtD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000351	0.014	CbGpPWpGaD
Lomitapide—Constipation—Etoposide—urinary bladder cancer	0.000349	0.00123	CcSEcCtD
Lomitapide—Asthenia—Gemcitabine—urinary bladder cancer	0.000342	0.00121	CcSEcCtD
Lomitapide—Haematuria—Epirubicin—urinary bladder cancer	0.000342	0.00121	CcSEcCtD
Lomitapide—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.000339	0.0012	CcSEcCtD
Lomitapide—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000339	0.0012	CcSEcCtD
Lomitapide—Nausea—Thiotepa—urinary bladder cancer	0.000337	0.00119	CcSEcCtD
Lomitapide—Urethral disorder—Methotrexate—urinary bladder cancer	0.000337	0.00119	CcSEcCtD
Lomitapide—Weight decreased—Doxorubicin—urinary bladder cancer	0.000336	0.00119	CcSEcCtD
Lomitapide—Sinusitis—Epirubicin—urinary bladder cancer	0.000336	0.00119	CcSEcCtD
Lomitapide—Feeling abnormal—Etoposide—urinary bladder cancer	0.000336	0.00119	CcSEcCtD
Lomitapide—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000333	0.00118	CcSEcCtD
Lomitapide—Infestation—Doxorubicin—urinary bladder cancer	0.000331	0.00117	CcSEcCtD
Lomitapide—Infestation NOS—Doxorubicin—urinary bladder cancer	0.000331	0.00117	CcSEcCtD
Lomitapide—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000327	0.00116	CcSEcCtD
Lomitapide—MTTP—Metabolism—UGT2B7—urinary bladder cancer	0.000326	0.013	CbGpPWpGaD
Lomitapide—Body temperature increased—Etoposide—urinary bladder cancer	0.000322	0.00114	CcSEcCtD
Lomitapide—Abdominal pain—Etoposide—urinary bladder cancer	0.000322	0.00114	CcSEcCtD
Lomitapide—Eye disorder—Methotrexate—urinary bladder cancer	0.000321	0.00114	CcSEcCtD
Lomitapide—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000321	0.00114	CcSEcCtD
Lomitapide—Asthenia—Cisplatin—urinary bladder cancer	0.000319	0.00113	CcSEcCtD
Lomitapide—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000319	0.00113	CcSEcCtD
Lomitapide—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000318	0.00113	CcSEcCtD
Lomitapide—Haematuria—Doxorubicin—urinary bladder cancer	0.000316	0.00112	CcSEcCtD
Lomitapide—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000316	0.00112	CcSEcCtD
Lomitapide—Urethral disorder—Epirubicin—urinary bladder cancer	0.000315	0.00112	CcSEcCtD
Lomitapide—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000313	0.00111	CcSEcCtD
Lomitapide—Sinusitis—Doxorubicin—urinary bladder cancer	0.000311	0.0011	CcSEcCtD
Lomitapide—Dizziness—Fluorouracil—urinary bladder cancer	0.00031	0.0011	CcSEcCtD
Lomitapide—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.00031	0.0011	CcSEcCtD
Lomitapide—Chills—Methotrexate—urinary bladder cancer	0.000308	0.00109	CcSEcCtD
Lomitapide—Diarrhoea—Cisplatin—urinary bladder cancer	0.000304	0.00108	CcSEcCtD
Lomitapide—Vomiting—Gemcitabine—urinary bladder cancer	0.000303	0.00108	CcSEcCtD
Lomitapide—CYP3A4—Estrogen metabolism—NQO1—urinary bladder cancer	0.000302	0.0121	CbGpPWpGaD
Lomitapide—Eye disorder—Epirubicin—urinary bladder cancer	0.000301	0.00106	CcSEcCtD
Lomitapide—Malnutrition—Methotrexate—urinary bladder cancer	0.000299	0.00106	CcSEcCtD
Lomitapide—Headache—Gemcitabine—urinary bladder cancer	0.000299	0.00106	CcSEcCtD
Lomitapide—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000298	0.00106	CcSEcCtD
Lomitapide—Vomiting—Fluorouracil—urinary bladder cancer	0.000298	0.00106	CcSEcCtD
Lomitapide—Headache—Fluorouracil—urinary bladder cancer	0.000294	0.00104	CcSEcCtD
Lomitapide—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000294	0.00104	CcSEcCtD
Lomitapide—MTTP—Metabolism—CYP4B1—urinary bladder cancer	0.000294	0.0117	CbGpPWpGaD
Lomitapide—Asthenia—Etoposide—urinary bladder cancer	0.000292	0.00104	CcSEcCtD
Lomitapide—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000292	0.00104	CcSEcCtD
Lomitapide—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000292	0.00103	CcSEcCtD
Lomitapide—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.00029	0.00103	CcSEcCtD
Lomitapide—Back pain—Methotrexate—urinary bladder cancer	0.000289	0.00103	CcSEcCtD
Lomitapide—Chills—Epirubicin—urinary bladder cancer	0.000289	0.00102	CcSEcCtD
Lomitapide—Nausea—Gemcitabine—urinary bladder cancer	0.000284	0.001	CcSEcCtD
Lomitapide—Vomiting—Cisplatin—urinary bladder cancer	0.000283	0.001	CcSEcCtD
Lomitapide—Malnutrition—Epirubicin—urinary bladder cancer	0.00028	0.000992	CcSEcCtD
Lomitapide—Diarrhoea—Etoposide—urinary bladder cancer	0.000279	0.000988	CcSEcCtD
Lomitapide—Nausea—Fluorouracil—urinary bladder cancer	0.000279	0.000988	CcSEcCtD
Lomitapide—Eye disorder—Doxorubicin—urinary bladder cancer	0.000278	0.000985	CcSEcCtD
Lomitapide—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000278	0.000983	CcSEcCtD
Lomitapide—MTTP—Metabolism—SLC19A1—urinary bladder cancer	0.000277	0.0111	CbGpPWpGaD
Lomitapide—Anaemia—Methotrexate—urinary bladder cancer	0.000276	0.00098	CcSEcCtD
Lomitapide—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000276	0.000978	CcSEcCtD
Lomitapide—Flatulence—Epirubicin—urinary bladder cancer	0.000276	0.000977	CcSEcCtD
Lomitapide—Back pain—Epirubicin—urinary bladder cancer	0.000271	0.000959	CcSEcCtD
Lomitapide—MTTP—Metabolism—PRSS3—urinary bladder cancer	0.00027	0.0108	CbGpPWpGaD
Lomitapide—Malaise—Methotrexate—urinary bladder cancer	0.00027	0.000956	CcSEcCtD
Lomitapide—Dizziness—Etoposide—urinary bladder cancer	0.00027	0.000955	CcSEcCtD
Lomitapide—Muscle spasms—Epirubicin—urinary bladder cancer	0.000269	0.000954	CcSEcCtD
Lomitapide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP4B1—urinary bladder cancer	0.000269	0.0107	CbGpPWpGaD
Lomitapide—Vertigo—Methotrexate—urinary bladder cancer	0.000269	0.000952	CcSEcCtD
Lomitapide—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000268	0.00095	CcSEcCtD
Lomitapide—Chills—Doxorubicin—urinary bladder cancer	0.000267	0.000946	CcSEcCtD
Lomitapide—CYP3A4—Oxidation by Cytochrome P450—CYP4B1—urinary bladder cancer	0.000265	0.0106	CbGpPWpGaD
Lomitapide—Nausea—Cisplatin—urinary bladder cancer	0.000264	0.000936	CcSEcCtD
Lomitapide—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.00026	0.00092	CcSEcCtD
Lomitapide—Vomiting—Etoposide—urinary bladder cancer	0.000259	0.000918	CcSEcCtD
Lomitapide—Malnutrition—Doxorubicin—urinary bladder cancer	0.000259	0.000918	CcSEcCtD
Lomitapide—Anaemia—Epirubicin—urinary bladder cancer	0.000259	0.000917	CcSEcCtD
Lomitapide—Headache—Etoposide—urinary bladder cancer	0.000255	0.000905	CcSEcCtD
Lomitapide—Flatulence—Doxorubicin—urinary bladder cancer	0.000255	0.000904	CcSEcCtD
Lomitapide—Arthralgia—Methotrexate—urinary bladder cancer	0.000255	0.000902	CcSEcCtD
Lomitapide—Chest pain—Methotrexate—urinary bladder cancer	0.000255	0.000902	CcSEcCtD
Lomitapide—Myalgia—Methotrexate—urinary bladder cancer	0.000255	0.000902	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000253	0.000896	CcSEcCtD
Lomitapide—Malaise—Epirubicin—urinary bladder cancer	0.000252	0.000894	CcSEcCtD
Lomitapide—Discomfort—Methotrexate—urinary bladder cancer	0.000252	0.000892	CcSEcCtD
Lomitapide—Vertigo—Epirubicin—urinary bladder cancer	0.000251	0.000891	CcSEcCtD
Lomitapide—Back pain—Doxorubicin—urinary bladder cancer	0.000251	0.000888	CcSEcCtD
Lomitapide—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000249	0.000882	CcSEcCtD
Lomitapide—Palpitations—Epirubicin—urinary bladder cancer	0.000247	0.000877	CcSEcCtD
Lomitapide—MTTP—Circadian rythm related genes—PTEN—urinary bladder cancer	0.000245	0.00978	CbGpPWpGaD
Lomitapide—Infection—Methotrexate—urinary bladder cancer	0.000243	0.000859	CcSEcCtD
Lomitapide—Nausea—Etoposide—urinary bladder cancer	0.000242	0.000858	CcSEcCtD
Lomitapide—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.00024	0.000852	CcSEcCtD
Lomitapide—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000239	0.000848	CcSEcCtD
Lomitapide—Anaemia—Doxorubicin—urinary bladder cancer	0.000239	0.000848	CcSEcCtD
Lomitapide—Myalgia—Epirubicin—urinary bladder cancer	0.000238	0.000844	CcSEcCtD
Lomitapide—Arthralgia—Epirubicin—urinary bladder cancer	0.000238	0.000844	CcSEcCtD
Lomitapide—Chest pain—Epirubicin—urinary bladder cancer	0.000238	0.000844	CcSEcCtD
Lomitapide—Skin disorder—Methotrexate—urinary bladder cancer	0.000237	0.00084	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000237	0.000839	CcSEcCtD
Lomitapide—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000236	0.000836	CcSEcCtD
Lomitapide—Discomfort—Epirubicin—urinary bladder cancer	0.000235	0.000834	CcSEcCtD
Lomitapide—MTTP—Circadian rythm related genes—EP300—urinary bladder cancer	0.000234	0.00932	CbGpPWpGaD
Lomitapide—Malaise—Doxorubicin—urinary bladder cancer	0.000234	0.000828	CcSEcCtD
Lomitapide—Dry mouth—Epirubicin—urinary bladder cancer	0.000233	0.000826	CcSEcCtD
Lomitapide—Vertigo—Doxorubicin—urinary bladder cancer	0.000233	0.000825	CcSEcCtD
Lomitapide—CYP3A4—Estrogen metabolism—GSTM1—urinary bladder cancer	0.000231	0.00924	CbGpPWpGaD
Lomitapide—Palpitations—Doxorubicin—urinary bladder cancer	0.000229	0.000811	CcSEcCtD
Lomitapide—Infection—Epirubicin—urinary bladder cancer	0.000227	0.000804	CcSEcCtD
Lomitapide—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000224	0.000794	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000222	0.000788	CcSEcCtD
Lomitapide—Skin disorder—Epirubicin—urinary bladder cancer	0.000222	0.000786	CcSEcCtD
Lomitapide—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000221	0.000783	CcSEcCtD
Lomitapide—Myalgia—Doxorubicin—urinary bladder cancer	0.000221	0.000781	CcSEcCtD
Lomitapide—Arthralgia—Doxorubicin—urinary bladder cancer	0.000221	0.000781	CcSEcCtD
Lomitapide—Chest pain—Doxorubicin—urinary bladder cancer	0.000221	0.000781	CcSEcCtD
Lomitapide—Paraesthesia—Methotrexate—urinary bladder cancer	0.000219	0.000777	CcSEcCtD
Lomitapide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000219	0.000776	CcSEcCtD
Lomitapide—CYP3A4—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.000218	0.0087	CbGpPWpGaD
Lomitapide—Discomfort—Doxorubicin—urinary bladder cancer	0.000218	0.000772	CcSEcCtD
Lomitapide—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.000217	0.00866	CbGpPWpGaD
Lomitapide—Somnolence—Methotrexate—urinary bladder cancer	0.000217	0.000769	CcSEcCtD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	0.000217	0.00865	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—TYMP—urinary bladder cancer	0.000216	0.00862	CbGpPWpGaD
Lomitapide—Dry mouth—Doxorubicin—urinary bladder cancer	0.000216	0.000764	CcSEcCtD
Lomitapide—Dyspepsia—Methotrexate—urinary bladder cancer	0.000215	0.000761	CcSEcCtD
Lomitapide—Decreased appetite—Methotrexate—urinary bladder cancer	0.000212	0.000752	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000211	0.000747	CcSEcCtD
Lomitapide—Fatigue—Methotrexate—urinary bladder cancer	0.00021	0.000746	CcSEcCtD
Lomitapide—Infection—Doxorubicin—urinary bladder cancer	0.00021	0.000744	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000208	0.000738	CcSEcCtD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	0.000208	0.00828	CbGpPWpGaD
Lomitapide—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000207	0.000735	CcSEcCtD
Lomitapide—Skin disorder—Doxorubicin—urinary bladder cancer	0.000205	0.000728	CcSEcCtD
Lomitapide—Paraesthesia—Epirubicin—urinary bladder cancer	0.000205	0.000727	CcSEcCtD
Lomitapide—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000204	0.000724	CcSEcCtD
Lomitapide—Somnolence—Epirubicin—urinary bladder cancer	0.000203	0.00072	CcSEcCtD
Lomitapide—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000201	0.000713	CcSEcCtD
Lomitapide—Dyspepsia—Epirubicin—urinary bladder cancer	0.000201	0.000713	CcSEcCtD
Lomitapide—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.0002	0.000707	CcSEcCtD
Lomitapide—Decreased appetite—Epirubicin—urinary bladder cancer	0.000199	0.000704	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000197	0.000699	CcSEcCtD
Lomitapide—Fatigue—Epirubicin—urinary bladder cancer	0.000197	0.000698	CcSEcCtD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—TFRC—urinary bladder cancer	0.000195	0.0078	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—NAT2—urinary bladder cancer	0.000195	0.0078	CbGpPWpGaD
Lomitapide—Constipation—Epirubicin—urinary bladder cancer	0.000195	0.000692	CcSEcCtD
Lomitapide—Abdominal pain—Methotrexate—urinary bladder cancer	0.000193	0.000684	CcSEcCtD
Lomitapide—Body temperature increased—Methotrexate—urinary bladder cancer	0.000193	0.000684	CcSEcCtD
Lomitapide—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000193	0.000682	CcSEcCtD
Lomitapide—Paraesthesia—Doxorubicin—urinary bladder cancer	0.00019	0.000673	CcSEcCtD
Lomitapide—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000188	0.000667	CcSEcCtD
Lomitapide—Somnolence—Doxorubicin—urinary bladder cancer	0.000188	0.000666	CcSEcCtD
Lomitapide—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000187	0.000662	CcSEcCtD
Lomitapide—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000186	0.000659	CcSEcCtD
Lomitapide—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000184	0.000651	CcSEcCtD
Lomitapide—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000182	0.000647	CcSEcCtD
Lomitapide—Fatigue—Doxorubicin—urinary bladder cancer	0.000182	0.000646	CcSEcCtD
Lomitapide—Constipation—Doxorubicin—urinary bladder cancer	0.000181	0.000641	CcSEcCtD
Lomitapide—Abdominal pain—Epirubicin—urinary bladder cancer	0.000181	0.00064	CcSEcCtD
Lomitapide—Body temperature increased—Epirubicin—urinary bladder cancer	0.000181	0.00064	CcSEcCtD
Lomitapide—Asthenia—Methotrexate—urinary bladder cancer	0.000175	0.000621	CcSEcCtD
Lomitapide—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000174	0.000617	CcSEcCtD
Lomitapide—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000173	0.000612	CcSEcCtD
Lomitapide—MTTP—Metabolism—RRM2—urinary bladder cancer	0.000169	0.00673	CbGpPWpGaD
Lomitapide—MTTP—Circadian rythm related genes—TP53—urinary bladder cancer	0.000167	0.00667	CbGpPWpGaD
Lomitapide—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000167	0.000592	CcSEcCtD
Lomitapide—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000167	0.000592	CcSEcCtD
Lomitapide—Diarrhoea—Methotrexate—urinary bladder cancer	0.000167	0.000592	CcSEcCtD
Lomitapide—Asthenia—Epirubicin—urinary bladder cancer	0.000164	0.000581	CcSEcCtD
Lomitapide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000162	0.00646	CbGpPWpGaD
Lomitapide—Dizziness—Methotrexate—urinary bladder cancer	0.000161	0.000572	CcSEcCtD
Lomitapide—Diarrhoea—Epirubicin—urinary bladder cancer	0.000156	0.000554	CcSEcCtD
Lomitapide—MTTP—Metabolism—ENO2—urinary bladder cancer	0.000156	0.00624	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—HPGDS—urinary bladder cancer	0.000156	0.00624	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	0.000155	0.0062	CbGpPWpGaD
Lomitapide—Vomiting—Methotrexate—urinary bladder cancer	0.000155	0.00055	CcSEcCtD
Lomitapide—Headache—Methotrexate—urinary bladder cancer	0.000153	0.000542	CcSEcCtD
Lomitapide—Asthenia—Doxorubicin—urinary bladder cancer	0.000152	0.000537	CcSEcCtD
Lomitapide—MTTP—Metabolism—GSTT1—urinary bladder cancer	0.000152	0.00605	CbGpPWpGaD
Lomitapide—Dizziness—Epirubicin—urinary bladder cancer	0.000151	0.000535	CcSEcCtD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	0.000149	0.00595	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—GSTZ1—urinary bladder cancer	0.000148	0.00592	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000146	0.00584	CbGpPWpGaD
Lomitapide—Vomiting—Epirubicin—urinary bladder cancer	0.000145	0.000515	CcSEcCtD
Lomitapide—Nausea—Methotrexate—urinary bladder cancer	0.000145	0.000514	CcSEcCtD
Lomitapide—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000145	0.000512	CcSEcCtD
Lomitapide—Headache—Epirubicin—urinary bladder cancer	0.000143	0.000507	CcSEcCtD
Lomitapide—CYP3A4—Biological oxidations—GSTO2—urinary bladder cancer	0.000141	0.00561	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—NAT1—urinary bladder cancer	0.000141	0.00561	CbGpPWpGaD
Lomitapide—Dizziness—Doxorubicin—urinary bladder cancer	0.00014	0.000495	CcSEcCtD
Lomitapide—CYP3A4—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000139	0.00553	CbGpPWpGaD
Lomitapide—Nausea—Epirubicin—urinary bladder cancer	0.000136	0.000481	CcSEcCtD
Lomitapide—Vomiting—Doxorubicin—urinary bladder cancer	0.000134	0.000476	CcSEcCtD
Lomitapide—Headache—Doxorubicin—urinary bladder cancer	0.000132	0.000469	CcSEcCtD
Lomitapide—CYP3A4—Biological oxidations—UGT2B7—urinary bladder cancer	0.000129	0.00513	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000127	0.00506	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—NQO1—urinary bladder cancer	0.000126	0.00503	CbGpPWpGaD
Lomitapide—Nausea—Doxorubicin—urinary bladder cancer	0.000126	0.000445	CcSEcCtD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	0.000122	0.00488	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—LIG1—urinary bladder cancer	0.000121	0.00481	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—TERT—urinary bladder cancer	0.000117	0.00467	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—CYP4B1—urinary bladder cancer	0.000116	0.00462	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000114	0.00456	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	0.000107	0.00425	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—GSTP1—urinary bladder cancer	0.000105	0.00419	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—FAS—urinary bladder cancer	0.000103	0.00412	CbGpPWpGaD
Lomitapide—MTTP—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	0.000102	0.00406	CbGpPWpGaD
Lomitapide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	9.97e-05	0.00398	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—TYMS—urinary bladder cancer	9.76e-05	0.0039	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—NCOR1—urinary bladder cancer	9.65e-05	0.00385	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—GSTM1—urinary bladder cancer	9.65e-05	0.00385	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—GPX1—urinary bladder cancer	9.24e-05	0.00369	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	9.19e-05	0.00367	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—CREBBP—urinary bladder cancer	9.15e-05	0.00365	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	9.13e-05	0.00365	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—ERCC2—urinary bladder cancer	9.07e-05	0.00362	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—MTHFR—urinary bladder cancer	8.53e-05	0.0034	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	8.33e-05	0.00333	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	7.7e-05	0.00307	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	7.6e-05	0.00303	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	7.35e-05	0.00294	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PPARG—urinary bladder cancer	6.92e-05	0.00276	CbGpPWpGaD
Lomitapide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—urinary bladder cancer	6.89e-05	0.00275	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—CREBBP—urinary bladder cancer	6.65e-05	0.00265	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—CXCL8—urinary bladder cancer	6.29e-05	0.00251	CbGpPWpGaD
Lomitapide—ABCB1—HIF-1-alpha transcription factor network—EP300—urinary bladder cancer	6.23e-05	0.00249	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	6.16e-05	0.00246	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	6.02e-05	0.0024	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—IL2—urinary bladder cancer	6.01e-05	0.0024	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	5.97e-05	0.00238	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	5.85e-05	0.00233	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	5.74e-05	0.00229	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PTGS2—urinary bladder cancer	5.44e-05	0.00217	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	5.09e-05	0.00203	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	4.91e-05	0.00196	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—PTEN—urinary bladder cancer	4.75e-05	0.00189	CbGpPWpGaD
Lomitapide—MTTP—Metabolism—EP300—urinary bladder cancer	4.53e-05	0.00181	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	4.5e-05	0.0018	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	4.48e-05	0.00179	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	4.46e-05	0.00178	CbGpPWpGaD
Lomitapide—ABCB1—Allograft Rejection—TNF—urinary bladder cancer	4.38e-05	0.00175	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	4.14e-05	0.00165	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GSTZ1—urinary bladder cancer	4.12e-05	0.00164	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	4.08e-05	0.00163	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	3.91e-05	0.00156	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GSTO2—urinary bladder cancer	3.9e-05	0.00156	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—NAT1—urinary bladder cancer	3.9e-05	0.00156	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	3.86e-05	0.00154	CbGpPWpGaD
Lomitapide—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	3.8e-05	0.00152	CbGpPWpGaD
Lomitapide—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	3.75e-05	0.0015	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—UGT2B7—urinary bladder cancer	3.57e-05	0.00142	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	3.32e-05	0.00132	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	3.27e-05	0.00131	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	3.21e-05	0.00128	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	3.2e-05	0.00128	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	3.03e-05	0.00121	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PRSS3—urinary bladder cancer	2.96e-05	0.00118	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	2.89e-05	0.00115	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	2.8e-05	0.00112	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	2.79e-05	0.00111	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	2.66e-05	0.00106	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	2.59e-05	0.00103	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	2.54e-05	0.00101	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	2.4e-05	0.000959	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—NAT1—urinary bladder cancer	2.4e-05	0.000959	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—TYMP—urinary bladder cancer	2.36e-05	0.000944	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	2.32e-05	0.000926	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	2.27e-05	0.000906	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	2.2e-05	0.000878	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	2.16e-05	0.000862	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	2.14e-05	0.000856	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—NAT2—urinary bladder cancer	2.14e-05	0.000853	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	1.98e-05	0.00079	CbGpPWpGaD
Lomitapide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	1.91e-05	0.00076	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	1.87e-05	0.000746	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—RRM2—urinary bladder cancer	1.85e-05	0.000737	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	1.82e-05	0.000727	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—HPGDS—urinary bladder cancer	1.71e-05	0.000682	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ENO2—urinary bladder cancer	1.71e-05	0.000682	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GSTT1—urinary bladder cancer	1.66e-05	0.000662	CbGpPWpGaD
Lomitapide—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.55e-05	0.000619	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—TYMP—urinary bladder cancer	1.46e-05	0.000581	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—NQO1—urinary bladder cancer	1.38e-05	0.00055	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1.32e-05	0.000526	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GSTP1—urinary bladder cancer	1.15e-05	0.000459	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.14e-05	0.000454	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—TYMS—urinary bladder cancer	1.07e-05	0.000426	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GSTM1—urinary bladder cancer	1.06e-05	0.000421	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—NCOR1—urinary bladder cancer	1.06e-05	0.000421	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.05e-05	0.00042	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.05e-05	0.00042	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.02e-05	0.000408	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—GPX1—urinary bladder cancer	1.01e-05	0.000404	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—ERCC2—urinary bladder cancer	9.93e-06	0.000396	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—MTHFR—urinary bladder cancer	9.33e-06	0.000372	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—NQO1—urinary bladder cancer	8.49e-06	0.000339	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PPARG—urinary bladder cancer	7.57e-06	0.000302	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—CREBBP—urinary bladder cancer	7.27e-06	0.00029	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	7.08e-06	0.000283	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—TYMS—urinary bladder cancer	6.58e-06	0.000263	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	6.51e-06	0.00026	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	6.51e-06	0.00026	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—GPX1—urinary bladder cancer	6.23e-06	0.000249	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	6.12e-06	0.000244	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PTGS2—urinary bladder cancer	5.95e-06	0.000238	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	5.75e-06	0.000229	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—PTEN—urinary bladder cancer	5.19e-06	0.000207	CbGpPWpGaD
Lomitapide—ABCB1—Metabolism—EP300—urinary bladder cancer	4.95e-06	0.000198	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PPARG—urinary bladder cancer	4.66e-06	0.000186	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	4.48e-06	0.000179	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	3.67e-06	0.000146	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—PTEN—urinary bladder cancer	3.2e-06	0.000128	CbGpPWpGaD
Lomitapide—CYP3A4—Metabolism—EP300—urinary bladder cancer	3.05e-06	0.000122	CbGpPWpGaD
